Canada’s Leading Research Universities

Developing talent, Driving innovation, Delivering impact.

USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19

Posted on

The Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) has been awarded a grant of almost $830,000 from the COVID-19 Therapeutics Accelerator to determine the effectiveness of several antiviral compounds against COVID-19….

https://www.vido.org/news/usask-vido-intervac-expands-international-role-to-test-antiviral-compounds-against-covid-19

Read More Impact Stories

Posted on

Spinal cord injury: stimulating neural plasticity to improve walking

This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Read more
Posted on

Unraveling the complexity of betacoronaviruses in bats

A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Read more
Posted on

Respiratory infections: better patient triage to relieve pressure on emergency departments

This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Read more
View All Impact Stories